Novo Nordisk on Tuesday received a broker downgrade, with the analysts arguing that its status as a duopoly in both diabetes and weight loss are under threat.
FlashNews:
Daniel JP O’Sullivan Unveils Within the Moon Book 1: Salvation, an Epic Science Fiction Adventure Exploring Humanity’s Forgotten Origins
Award-Winning Storytelling Meets Bold Relationship Exploration in Wade Alan’s Passions Shared Trilogy
Man with Guns Shares the Unspoken Reality of Domestic Violence in His Memoir Hillbilly Whispers
What Happens When the Heart Can No Longer Stay Silent? Faye Munnings Explores the Answer in Silent Shouting
Vietnam Veteran Kenneth “Stoney” Timberlake Shares a Lifetime of Unforgettable Stories in Wild One
Jenise R. McNair Celebrates Third Amazon Bestseller With “The Positioned for More Experience”
WealthInvest.ai Highlights a Security-First Approach to AI-Powered Crypto Trading and Portfolio Management
Kenya moves 30 million academic credentials onto Avalanche blockchain
AIDesignHouse Brings AI-Powered Visual Planning to Home Design Projects
AstraZeneca and Bristol-Myers: when Big Pharma isn’t big enough
AstraZeneca investors raise concerns over mega-merger talks
BlackRock launches tokenized money market funds for stablecoin reserves
Did you solve it? Are you a match for the world’s smartest teen?
Coinwore Strengthens Proof of Reserves Framework to Enhance Platform Transparency and Security Standards
Avalcoin.com Strengthens Proof of Reserves Framework to Enhance Platform Transparency and Security Standards
Avalcoin.com Advances Cross-Chain Integration, Infrastructure Innovation, and Ecosystem Collaboration to Build the Next Generation of Digital Asset Services
AVALCOIN and Kraken Representatives Hold Strategic Discussion in New York on the Future of Digital Asset Infrastructure
Coinwore Advances Cross-Chain Integration, Infrastructure Innovation, and Ecosystem Collaboration to Build Next-Generation Digital Asset Services
Coinwore Advances Multi-State MTL Licensing Process, Accelerating U.S. Compliance Expansion and Strengthening Digital Asset Infrastructure
Home » Ozempic maker Novo Nordisk gets another downgrade. The end’s in sight for its duopoly status, says TD Cowen.